Tech Company Financing Transactions
Vasa Therapeutics Funding Round
On 1/3/2024, Vasa Therapeutics raised $6 million in Seed funding from NuFund Venture Group, Orphinic Scientific and Seedfolio.
Transaction Overview
Company Name
Announced On
1/3/2024
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to advance novel therapies for cardiovascular diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
533 2nd St 350
Encinitas, CA 92024
USA
Encinitas, CA 92024
USA
Phone
Undisclosed
Website
Email Address
Overview
Vasa Therapeutics, Inc. is a private, preclinical-stage biopharmaceutical company committed to the discovery and development of therapeutics that target the pathophysiology of cardiovascular aging. Vasa has locations in California and Poland, strategically placed in vibrant academic and biotechnology innovation centers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Artur Plonowski
Chief Scientific Officer
Derek Cole
Co-Founder
Benjamin Pratt
Browse more venture capital transactions:
Prev: 1/3/2024: Agorus venture capital transaction
Next: 1/3/2024: Radionetics Oncology venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs